New antiplatelet agents: are we better off now than we were with aspirin?
Coccheri, S.
Clinical Advances in Hematology and Oncology H&o 11(12): 787-790
2013
ISSN/ISBN: 1543-0790 PMID: 24893282 Document Number: 670524
Document emailed within 1 workday
Related Documents
Hostetter, J.C.; Bhatt, D.L. 2003: The expanding role of antiplatelet agents in coronary artery disease. a current review of aspirin, glycoprotein IIb/IIIa inhibitors, and the thienopyridines Minerva Cardioangiologica 51(5): 531-546Mittal, S.R. 2001: Antiplatelet effect of aspirin--need for further research Journal of the Association of Physicians of India 49: 493
Celestini, A.; Pulcinelli, F.M.; Pignatelli, P.; Lenti, L.; Frati, G.; Gazzaniga, P.Paolo.; Violi, F. 2002: Vitamin E potentiates the antiplatelet activity of aspirin in collagen-stimulated platelets Haematologica 87(4): 420-426
Bhatt, D.L.; Kapadia, S.R.; Bajzer, C.T.; Chew, D.P.; Ziada, K.M.; Mukherjee, D.; Roffi, M.; Topol, E.J.; Yadav, J.S. 2001: Dual antiplatelet therapy with clopidogrel and aspirin after carotid artery stenting Journal of Invasive Cardiology 13(12): 767-771
Pignone, M.; Mulrow, C. 2002: Antiplatelet therapy and atherosclerotic events. Risks and patients' values need to be included in decision about aspirin for prevention of coronary heart disease Bmj 324(7342): 917
Gomes, O.M. 1982: Antiplatelet agents: how much? which one? for whom? Arquivos Brasileiros de Cardiologia 38(1): 1-2
Ishikawa, K. 2003: Anticoagulant, antiplatelet agents Nihon Rinsho. Japanese Journal of Clinical Medicine 61(Suppl 4): 647-653
De Caterina, R.; Blanco, A. 1992: Nitrates as antiplatelet agents Sangre 37(1): 31-38
Bochenek, A.; Wilczyński, M.ła. 2006: Antiplatelet agents--problem for cardiac surgeon Kardiologia Polska 64(11): 1329-1331
De Gautard, G.; Perrier, A. 2014: Antiplatelet agents in secondary prevention of stroke Revue Medicale Suisse 10(446): 1902 1904-7
Hegge, K.A. 2009: Antiplatelet agents for prevention of recurrent ischemic stroke South Dakota Medicine: the Journal of the South Dakota State Medical Association 62(1): 15-17
Griguer, R.P.; Brochier, M.; Raynaud, R. 1973: The place of fibrinolytic and antiplatelet-aggregation agents in therapy Annales de Cardiologie et d'Angeiologie 22(6): 461-472
Zoja, C.; Perico, N.; Remuzzi, G. 1991: Antiplatelet agents: effects on the progressive renal disease American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 17(5 Suppl 1: 98-102
Satoh, S. 2011: Usage of antiplatelet and anticoagulant agents in ischemic cardiomyopathy Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 9): 423-427
Teng, C.M.; Ko, F.N.; Wang, J.P.; Lin, C.N.; Wu, T.S.; Chen, C.C.; Huang, T.F. 1991: Antihaemostatic and antithrombotic effect of some antiplatelet agents isolated from Chinese herbs Journal of Pharmacy and Pharmacology 43(9): 667-669
Kawana, S.; Katori, M.; Ohta, M.; Nishiyama, S. 1986: Microcirculatory changes during skin allograft rejection and prolongation of survival time by antiplatelet agents International Journal of Tissue Reactions 8(2): 119-128
Schaerlig, E. 2010: Echoes of the ESC 2010. Atrial fibrillation, rush on antiplatelet agents, genetics omnipresence Revue medicale suisse 6(270): 2151-2152
Melandri, G.; Semprini, F.; Cervi, V.; Candiotti, N.; Branzi, A. 1994: Chronic ischemic cardiopathy: antiplatelet agents and anticoagulants, new protocols for prevention and treatment Cardiologia 39(12 Suppl. 1): 347-352
Bussey, H.I. 2004: An overview of anticoagulants, antiplatelet agents, and the combination in patients with mechanical heart valves Journal of Heart Valve Disease 13(3): 319-324
Wang, Y.-m.; Cao, Y.-j.; Liu, C.-f.; Feng, P. 2007: The changes and effects of antiplatelet agents on platelet-leukocyte aggregation in patients with acute cerebral infarction Zhonghua Nei Ke Za Zhi 46(7): 562-565